Calamos Wealth Management LLC Trims Position in UnitedHealth Group Incorporated (NYSE:UNH)

Calamos Wealth Management LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 18.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,729 shares of the healthcare conglomerate’s stock after selling 7,442 shares during the period. UnitedHealth Group comprises about 0.9% of Calamos Wealth Management LLC’s investment portfolio, making the stock its 23rd biggest position. Calamos Wealth Management LLC’s holdings in UnitedHealth Group were worth $17,142,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Financial Management Professionals Inc. lifted its position in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after buying an additional 17 shares in the last quarter. Richwood Investment Advisors LLC boosted its position in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after acquiring an additional 20 shares during the last quarter. Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after purchasing an additional 20 shares during the last quarter. Kolinsky Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock worth $1,080,000 after buying an additional 21 shares during the last quarter. Finally, Retirement Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after acquiring an additional 21 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $308.69 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $280.03 billion, a price-to-earnings ratio of 12.93, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45. The firm has a 50 day moving average of $327.18 and a 200 day moving average of $448.90. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm earned $6.91 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the firm’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director owned 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have bought 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on UNH shares. UBS Group dropped their target price on UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating for the company in a report on Wednesday, June 25th. TD Securities reiterated a “hold” rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. TD Cowen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. KeyCorp decreased their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. Finally, Wells Fargo & Company reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Friday, June 6th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $415.57.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.